Ardiyon Bio
PrivateLast Round
Accelerator
Jan 1, 2025
Total Funding Raised
$40,000
Company Overview
Ardiyon Bio is a biotechnology company developing a targeted enzyme replacement therapy for systemic lupus erythematosus and related autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
systemic lupus erythematosusSLEenzyme replacement therapybiotech startupDNASE1L3autoimmune diseasedrug discoveryPEGylationbiologicstherapeutic pipelineimmunologypreclinical researchpharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ardiyon Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ardiyon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2025 |
Ardiyon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Texas Tech Accelerator | Accelerator |
Ardiyon Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ardiyon Bio's valuation, stock price, and market status.